SEONGNAM, South Korea I 12, 2024 I SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention ...

NORTH CHICAGO, IL and MADISON, WI, USA I 13, 2024 I AbbVie (NYSE: ABBV) and Nimble Therapeutics today announced a definitive agreement under which ...

ZUG, Switzerland I 13, 2024 I Galderma (SWX:GALD) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved ...

UNLOXCYT is the first and only FDA-approved anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma ...

— Following recently signed global license agreement with Synaffix, EO-1022 leverages the company’s GlycoConnect® and HydraSpace® ADC technologies for glycan site-specific conjugation and SYNstatin E™ ...

REDWOOD CITY, CA, USA I December 11, 2024 I Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and ...

WILMINGTON, DE, USA I 11, 2024 I Updated results from the OlympiA Phase III trial showed AstraZeneca and Merck & Co., Inc’s, known as MSD outside of the US and Canada, LYNPARZA ® (olaparib) ...

NEW YORK, NY, USA I 05, 2024 I Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the ...

BOSTON, MA, USA I 11, 2024 I Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced ...

ATLANTA, GA, USA I December 11, 2024 I Expression Therapeutics, Inc., has presented the results of a Phase 1 clinical trial for its novel lentiviral ...

Interim data from Phase 1/2a study demonstrate near complete inhibition in hemolytic activity and functional activity of alternative complement pathway ...

Statistically significant difference in arrested disease in leriglitazone treated patients when compared to the natural history of the disease ...